Medicared For All Logo

Richard Mascolo in Doylestown, Pennsylvania

Home Pennsylvania Doylestown

Richard Mascolo has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 315 W State St in Doylestown, Pennsylvania.

They're a part of the: Via Affiliates medical group which has around 177 members. You can call their office at 215-345-6050 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended State University Of Ny Upstate Medical University and graduated in 1994 (around 30 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Richard Mascolo Office Phone and Directions

Richard Mascolo
Via Affiliates
315 W State St
Doylestown, Pennsylvania 18901
215-345-6050


Patient Ratings
Please rate your experience with Richard Mascolo below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 215-345-6050


Enter a starting address:


Healthcare Info for Richard Mascolo

Medical School: State University Of Ny Upstate Medical University
Graduation Year: 1994
The Primary Medical Specialty for Richard Mascolo is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 30
PAC (PECOS ID)#: 2264558402
NPI #: 1225079965
NPI Created On: 06/10/2006
NPI Last Updated Listed as: 07/15/2019
Primary Taxonomy Code: 207RC0000X
License Number:
MD-418667
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • Highmark Health Insurance Company
  • AmeriHealth HMO, Inc.
  • Humana
  • Highmark Inc.
  • UPMC Health Options, Inc.
  • Pennsylvania Health & Wellness, Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  2. Routine ekg using at least 12 leads including interpretation and report
  3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  7. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  8. Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report
  9. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
  10. Remote evaluations of defibrillator up to 90 days with analysis, review and report
  11. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
  12. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
  13. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  14. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  15. Follow-up or limited ultrasound examination of heart
  16. Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
  17. New patient office or other outpatient visit, typically 45 minutes
  18. Established patient office or other outpatient visit, typically 15 minutes
  19. Established patient office or other outpatient, visit typically 25 minutes
  20. Initial hospital inpatient care, typically 70 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788006439

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788006437

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $11

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783640689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813060157

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832801331

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832812311

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833222913

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833222917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: CARDIOVASCULAR

Name Of Drug #2:: VYNDAQEL

Associated Drug #2: 0069-8729-55


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848395917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: VERQUVO

Open Associated Drug #1: 0006-5030-01


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 815059863

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Vascepa

Open Associated Drug #1: 52937-101-08


Cardiovascular Disease (cardiology) Professionals in Doylestown

599 W State St
Doylestown, PA
Via Affiliates

315 W State St
Doylestown, PA
Via Affiliates

599 W State St
Doylestown, PA
Via Affiliates

599 W State St
Doylestown, PA
Via Affiliates

599 W State St
Doylestown, PA
Via Affiliates

315 W State St
Doylestown, PA
Via Affiliates

Providers in Via Affiliates

1.Huda Abbas

593 W State Str 3rd Floor
Doylestown Pa 18901-2554
Via Affiliates
Hospitalist

2.Huda Abbas

595 N W St
Doylestown Pa 18901-2554
Via Affiliates
Hospitalist

3.Huda Abbas

599 W State St
Doylestown Pa 18901-2554
Via Affiliates
Hospitalist

4.Lynn Acquaviva

4897 York Rd
Buckingham Pa 18901
Via Affiliates
Family Practice

5.Lynn Acquaviva

847 Easton Rd
Warrington Pa 18976-2908
Via Affiliates
Family Practice

6.Adedotun Adebamiro

595 W State St
Doylestown Pa 18901-2554
Via Affiliates
Internal Medicine

View all 177 members of Via Affiliates medical group